In the context of acquired resistance to immunotherapy, CD8+ T cells in lung cancer often display elevated expression of multiple inhibitory receptors, such as PD-1, T cell immunoglobulin and mucin-domain containing-3(TIM-3), and Lymphocyte activation gene-3(LAG-3) (36, 37). The gene discussed is PDCD1; the disease is lung cancer.